-
Marianne Berdugo
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
-
Riad A. Bejjani
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
-
Fatemeh Valamanesh
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
Rothschild Foundation, Paris, France; the
-
Michele Savoldelli
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
Department of Ophthalmology, Hôtel-Dieu Paris, Paris, France;
-
Jean-Claude Jeanny
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
-
Dominique Blanc
Steba Biotech, Rehovot, Israel; and the
-
Herve Ficheux
Steba Biotech, Rehovot, Israel; and the
-
Avigdor Scherz
Weizmann Institute of Science, Rehovot, Israel.
-
Yoram Salomon
Weizmann Institute of Science, Rehovot, Israel.
-
David BenEzra
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
-
Francine Behar-Cohen
From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Université Paris Descartes, Paris, France; the
Rothschild Foundation, Paris, France; the
Department of Ophthalmology, Hôtel-Dieu Paris, Paris, France;